HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 425 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $762,000 | +26.6% | 13,371 | -12.1% | 0.02% | 0.0% |
| Q3 2022 | $602,000 | -9.2% | 15,212 | +1.0% | 0.02% | 0.0% |
| Q2 2022 | $663,000 | -15.6% | 15,061 | -67.1% | 0.02% | +750.0% |
| Q2 2019 | $786,000 | +6.6% | 45,778 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $737,000 | +10.0% | 45,778 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $670,000 | -19.5% | 45,778 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $832,000 | +128.6% | 45,778 | +112.4% | 0.00% | +100.0% |
| Q2 2018 | $364,000 | -6.7% | 21,550 | +8.3% | 0.00% | 0.0% |
| Q1 2018 | $390,000 | – | 19,906 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 1,129,551 | $47,091,000 | 6.38% |
| First Light Asset Management, LLC | 2,011,350 | $83,853,000 | 5.56% |
| TRAN CAPITAL MANAGEMENT, L.P. | 1,353,208 | $56,415,000 | 5.03% |
| SNYDER CAPITAL MANAGEMENT L P | 2,920,860 | $121,771,000 | 3.50% |
| DOHENY ASSET MANAGEMENT /CA | 120,028 | $5,004,000 | 3.39% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 104,945 | $4,375,000 | 2.39% |
| Redwood Investments, LLC | 542,764 | $22,628,000 | 1.99% |
| Kent Lake Capital LLC | 85,000 | $3,544,000 | 1.44% |
| Lisanti Capital Growth, LLC | 263,460 | $10,984,000 | 1.41% |
| Bellevue Group AG | 3,011,966 | $125,569,000 | 1.33% |